Literature DB >> 3686754

Effects of verapamil and sodium nitroprusside on acetylcholine-induced contraction of the rabbit detrusor muscle.

M Gotoh1, A Kondo, M Hassouna, M M Elhilali.   

Abstract

Effects of extracellular and intracellular Ca2+ on acetylcholine-induced contraction of the bladder detrusor muscle were studied in vitro, utilizing two types of Ca2+ antagonists of different mechanisms of action; verapamil and sodium nitroprusside (NP). Acetylcholine (10(-8) to 10(-2) M) caused dose-dependent contractions of the detrusor muscle strips. Pretreatment of the strips with verapamil (10(-7), 10(-6) M) significantly inhibited the acetylcholine-induced contraction in a dose-dependent manner, whereas NP (10(-7) to 10(-5) M) failed so suppress the contraction. The contraction of the strips once elicited by acetylcholine (10(-6) M) could be completely relaxed by verapamil (10(-5) M) addition, but only incompletely by NP (10(-5), 10(-4) M). In Ca2+-free solution containing 0.01 mM EGTA, replenishment of Ca2+ (2.5 mM) to the medium caused contractions of the strips. Addition of acetylcholine (10(-6) M) to the medium enhanced the Ca2+-induced contraction, which was significantly inhibited by pretreatment with verapamil (10(-6) M), but not affected by NP (10(-6) M). In Ca2+-free medium containing 0.1 mM EGTA, acetylcholine caused a slight degree of tension increase of the strips in a dose-dependent fashion, at higher concentrations exceeding 10(-6) M. These results suggest that the detrusor muscle contraction induced by acetylcholine is mostly dependent of extracellular Ca2+ influx both in its initiation and maintenance. It is also supposed, however, that intracellular Ca2+ fractions will partly participate in the acetylcholine-induced contraction and possibly in its maintenance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686754     DOI: 10.1007/bf00258192

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

Review 1.  Drug therapy. Sodium nitroprusside.

Authors:  R F Palmer; K C Lasseter
Journal:  N Engl J Med       Date:  1975-02-06       Impact factor: 91.245

2.  In vitro dog detrusor strip contractile responses and calcium ion activity.

Authors:  T J Rohner; T C Bolton; K A Berkich; E J Sanford
Journal:  Invest Urol       Date:  1976-07

3.  The effect of sodium nitroprusside on the uptake and efflux of 45Ca from rabbit and rat vessels.

Authors:  T T Zsotér; N F Henein; C Wolchinsky
Journal:  Eur J Pharmacol       Date:  1977-09-01       Impact factor: 4.432

4.  Mode of action of sodium nitroprusside on vascular smooth muscle.

Authors:  V A Kreye; G D Baron; J B Lüth; H Schmidt-Gayk
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the cat.

Authors:  K E Andersson; L Edvinsson; E T MacKenzie; T Skärby; A R Young
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

6.  Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo.

Authors:  A Forman; K E Andersson; L Henriksson; T Rud; U Ulmsten
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-08

7.  Differing actions of nitroprusside and D-600 on tension and 45Ca fluxes in canine renal arteries.

Authors:  R K Hester; G B Weiss; W J Fry
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

8.  Interactions of calcium, prostaglandins and indomethacin on the smooth muscle of the bladder.

Authors:  G F Anderson; K I Kohn
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

Review 9.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

10.  Effects of calcium and verapamil on vesicourethral smooth muscle of rabbits.

Authors:  O P Khanna; E J Barbieri; M Moss; D Son; R F McMichael
Journal:  Urology       Date:  1983-03       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.